PL3618848T3 - Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne - Google Patents

Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne

Info

Publication number
PL3618848T3
PL3618848T3 PL18729327T PL18729327T PL3618848T3 PL 3618848 T3 PL3618848 T3 PL 3618848T3 PL 18729327 T PL18729327 T PL 18729327T PL 18729327 T PL18729327 T PL 18729327T PL 3618848 T3 PL3618848 T3 PL 3618848T3
Authority
PL
Poland
Prior art keywords
biologically active
therapeutic applications
active complexes
complexes
therapeutic
Prior art date
Application number
PL18729327T
Other languages
English (en)
Inventor
Aftab NADEEM
Catharina Svanborg
Chin Shing. HO
Original Assignee
Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamlet Pharma Ab filed Critical Hamlet Pharma Ab
Publication of PL3618848T3 publication Critical patent/PL3618848T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Inorganic Chemistry (AREA)
PL18729327T 2017-05-14 2018-05-14 Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne PL3618848T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1707715.7A GB201707715D0 (en) 2017-05-14 2017-05-14 Preperation of biologically active complexes
PCT/EP2018/062396 WO2018210759A1 (en) 2017-05-14 2018-05-14 Preparation of biologically active complexes
EP18729327.9A EP3618848B1 (en) 2017-05-14 2018-05-14 Biologically active complexes and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
PL3618848T3 true PL3618848T3 (pl) 2021-06-14

Family

ID=59201543

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20208669.0T PL3811967T3 (pl) 2017-05-14 2018-05-14 Wytwarzanie biologicznie aktywnych kompleksów
PL18729327T PL3618848T3 (pl) 2017-05-14 2018-05-14 Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL20208669.0T PL3811967T3 (pl) 2017-05-14 2018-05-14 Wytwarzanie biologicznie aktywnych kompleksów

Country Status (13)

Country Link
US (3) US20200140481A1 (pl)
EP (2) EP3811967B1 (pl)
JP (2) JP7672122B2 (pl)
KR (2) KR20200015557A (pl)
CN (2) CN119700935A (pl)
AU (1) AU2018269304B2 (pl)
CA (1) CA3063285A1 (pl)
DK (2) DK3618848T3 (pl)
ES (2) ES2973290T3 (pl)
FI (1) FI3811967T3 (pl)
GB (1) GB201707715D0 (pl)
PL (2) PL3811967T3 (pl)
WO (1) WO2018210759A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201621752D0 (en) * 2016-12-20 2017-02-01 Hamlet Pharma Ab Therapeutically active complexes
GB201707715D0 (en) * 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes
GB2574845A (en) * 2018-06-20 2019-12-25 Hamlet Pharma Ab Therapeutically active complexes
WO2019243547A1 (en) * 2018-06-20 2019-12-26 Hamlet Pharma Ab Therapeutically active complexes
WO2021032807A1 (en) * 2019-08-20 2021-02-25 Hamlet Pharma Ab Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy
GB202015836D0 (en) * 2020-10-06 2020-11-18 Hamlet Pharma Ab Compositions
WO2024075003A1 (en) 2022-10-03 2024-04-11 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537273A1 (en) * 2003-09-05 2005-03-17 Gtc Biotherapeutics, Inc. Method for the production of fusion proteins in transgenic mammal milk
CN102348721A (zh) 2009-01-09 2012-02-08 哈姆雷特药品Ab 复合物和生产过程
WO2010131237A1 (en) 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
GB0908279D0 (en) 2009-05-14 2009-06-24 Enovate Systems Ltd Subsea winch
DK2643010T3 (en) * 2010-11-24 2017-02-27 Hamlet Pharma Ab BIOLOGICAL ACTIVE COMPLEX AND ITS PREPARATION
ES2844874T3 (es) * 2012-08-09 2021-07-23 Hamlet Pharma Ab Complejo de proteína de leche y ácido graso
GB201621752D0 (en) * 2016-12-20 2017-02-01 Hamlet Pharma Ab Therapeutically active complexes
GB201707715D0 (en) 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes

Also Published As

Publication number Publication date
DK3811967T5 (da) 2024-08-19
CN110650746B (zh) 2024-12-31
ES2861252T3 (es) 2021-10-06
KR20200015557A (ko) 2020-02-12
CN119700935A (zh) 2025-03-28
US12331073B2 (en) 2025-06-17
CN110650746A (zh) 2020-01-03
WO2018210759A1 (en) 2018-11-22
PL3811967T3 (pl) 2024-03-18
KR20260021814A (ko) 2026-02-13
JP2023075290A (ja) 2023-05-30
EP3618848A1 (en) 2020-03-11
CA3063285A1 (en) 2018-11-22
EP3811967B1 (en) 2023-12-20
US20210130394A1 (en) 2021-05-06
JP7705160B2 (ja) 2025-07-09
JP7672122B2 (ja) 2025-05-07
EP3618848B1 (en) 2020-11-25
AU2018269304B2 (en) 2025-02-27
DK3618848T3 (da) 2021-03-01
ES2973290T3 (es) 2024-06-19
AU2018269304A1 (en) 2019-11-21
EP3811967A1 (en) 2021-04-28
GB201707715D0 (en) 2017-06-28
FI3811967T3 (fi) 2023-12-28
US20200140481A1 (en) 2020-05-07
JP2020519673A (ja) 2020-07-02
DK3811967T3 (da) 2024-01-08
US20260085088A1 (en) 2026-03-26

Similar Documents

Publication Publication Date Title
PL3618848T3 (pl) Biologicznie aktywne kompleksy i ich zastosowania terapeutyczne
IL279897A (en) Fusosome compositions and uses thereof
IL283376A (en) Multivariate and other metal-organic frameworks, and uses thereof
IL285053A (en) Hsd17b13 variants and uses thereof
EP3684365A4 (en) PROTEIN DEGRADATION AGENTS AND USES OF SUCH
PL3630917T3 (pl) Równomiernie zamknięte nanocząstki i ich zastosowania
PL4234581T3 (pl) Przeciwciała terapeutyczne i ich zastosowania
EP3709912A4 (en) DRUG DELIVERY SYSTEMS AND METHODS
PL3661954T3 (pl) Muteiny interleukiny 21 i sposoby leczenia
EP3565516A4 (en) INFUSION SYSTEM AND ITS COMPONENTS
DK3922279T3 (da) Præparater til lægemiddelafgivelse og anvendelse heraf
IL255228A0 (en) Constructs targeting hpv16-e7 peptide/mhc complexes and uses thereof
EP3893945A4 (en) CROMOGLYC ESTERS AND THEIR USES
EP3719050A4 (en) COMPOUND, AND PELLET
DK3514153T3 (da) Pyrimidinforbindelse og farmaceutisk anvendelse deraf
EP3580236A4 (en) ANTI-G-CSF ANTIBODIES AND ASSOCIATED USES
HUE055762T2 (hu) Nyújtott hatású készítmények
EP3526186A4 (en) SUBSTITUTED HYDROXY STYLENE AND THEIR THERAPEUTIC APPLICATIONS
PL3720875T3 (pl) Peptydy przeciwdrobnoustrojowe i sposoby ich stosowania
EP3697265A4 (en) DISPLACEMENT AND DISCOVERY SEAT
PL3986419T3 (pl) Pochodne kwasu boronowego i ich zastosowania terapeutyczne
EP3672387C0 (en) AGRICULTURAL TILLING SET AND COMPONENTS
MA50358A (fr) Sémaglutide en thérapie médicale
EP3558450A4 (en) NEUROSTIMULATORS AND STIMULATION SYSTEMS
DK3512544T3 (da) Peptidforbindelser og terapeutiske anvendelser deraf